The project is in a healthy, maintained state
DaVinci US Drug Formulary Test Kit
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
 Dependencies

Development

Runtime

~> 0.2.0
>= 0.4.37
 Project Readme

DaVinci US Drug Formulary Test Kit

This is an Inferno test kit for the DaVinci Payer Data Exchange (PDex) US Drug Formulary Implementation Guide v2.0.1.

Instructions

Refer to the Inferno Framework Documentation for instructions on how to run this test kit.

Status

These tests check the following behaviors as defined in the IG:

  • FHIR Interactions
    • Capabilities
    • Read
    • Search
      • Individual search parameters
      • _include searches
  • FHIR Data
    • Validation against IG profiles
    • Presence of all Must Support fields
      • Resolution of Must Support references

Known Issues

The following areas of the IG are not fully tested:

  • Must Support checks are not performed for all elements of Formulary Drug resources due to the use of an intensional value set for slicing MedicationKnowledge.code.coding elements.
  • The following search features are not tested:
    • Combination searches
    • Multiple Or
    • Multiple And
    • Comparators

Reporting Issues

Please report any problems with these tests in Github Issues. The team may also be reached in the #inferno Zulip stream.

License

Licensed under the Apache License, Version 2.0 (the "License"); you may not use this file except in compliance with the License. You may obtain a copy of the License at

http://www.apache.org/licenses/LICENSE-2.0

Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.

Trademark Notice

HL7, FHIR and the FHIR [FLAME DESIGN] are the registered trademarks of Health Level Seven International and their use does not constitute endorsement by HL7.